Article info
PDFPulmonary vascular disease
Original research article
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
- Correspondence to Dr Robert D Brook, Division of Cardiovascular Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., PO Box 322, Ann Arbor, MI 48106, USA; robdbrok{at}umich.edu
Citation
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
Publication history
- Received November 15, 2016
- Revised March 8, 2017
- Accepted March 9, 2017
- First published April 17, 2017.
Online issue publication
January 18, 2021
Article Versions
- Previous version (13 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/